Hetero gets DCGI nod to manufacture, market Molnupiravir capsules

Under the licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries, following the approvals for emergency use authorisation by local regulatory agencies.